SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001104659-19-000559
Filing Date
2019-01-03
Accepted
2019-01-03 17:17:37
Documents
2
Period of Report
2018-10-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A a19-1051_18ka.htm 8-K/A 21138
2 EX-99.1 a19-1051_1ex99d1.htm EX-99.1 56176
  Complete submission text file 0001104659-19-000559.txt   78577
Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Filer) CIK: 0001583107 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-36033 | Film No.: 19506935
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1